Navigation Links
Researchers test inhalable measles vaccine
Date:2/1/2011

Sustained high vaccination coverage is key to preventing deaths from measles. Despite the availability of a vaccine, measles remains an important killer of children worldwide, particularly in less-developed regions where vaccination coverage is limited. A team of researchers, led by scientists at the Johns Hopkins Bloomberg School of Public Health and the University of Colorado, developed and successfully tested a dry powder, live-attenuated measles vaccine that can be inhaled. The novel vaccine was studied in rhesus macaques. Results of the study are published in the January 31 edition of the journal PNAS.

The current measles vaccine requires two injections to provide full immunityone given at 9 to 12 months of age and another later in childhood. Special training for needle and syringe injections is needed to administer the vaccine, which requires refrigeration and is shipped as a powder that must be reconstituted and kept on ice in the field clinic. Such injections increase the risk of exposure to blood borne diseases.

According to the study, the new dry powder measles vaccine provided the macaques complete protection from measles with a single vaccine dose. The vaccine was delivered by aerosol using either one of two dry powder inhalers, the PuffHaler and the BD Solovent. No adverse effects were observed.

"An effective dry powder vaccine would be tremendously helpful in less developed regions where resources are limited," said Diane E. Griffin, MD, PhD, senior author of the study and chair of the W. Harry Feinstone Department of Molecular Microbiology and Immunology at the Bloomberg School of Public Health. "This vaccine can be shipped as powder and does not require reconstitution or special training to administer, which could greatly increase the ease and safety of measles vaccination worldwide."

Before a vaccine was developed in 1963, there were 130 million cases of measles each year resulting in more than 7 million deaths annually. Measles deaths were estimated to be 164,000 in 2008. Human trials for the dry powder measles vaccine are in development in India.

"The tests of inhalable dry powder vaccine at Johns Hopkins provide confidence that it can safely be tested in human volunteers after regulatory permission is given by Indian authorities," said Robert Sievers, professor at the CU Boulder and a Fellow of the Cooperative Institute of Research in Environmental Sciences. He is also CEO of Aktiv-Dry LLC and co-inventor of the PuffHaler and the new vaccine microparticles.


'/>"/>

Contact: Tim Parsons
tmparson@jhsph.edu
410-955-7619
Johns Hopkins University Bloomberg School of Public Health
Source:Eurekalert

Related biology news :

1. NC State researchers get to root of parasite genome
2. Researchers find animal with ability to survive climate change
3. Researchers find an essential gene for forming ears of corn
4. Researchers note differences between people and animals on calorie restriction
5. Researchers study acoustic communication in deep-sea fish
6. Researchers discover that growing up too fast may mean dying young in honey bees
7. Researchers study how pistachios may improve heart health
8. UI researchers find potentially toxic substance present in Chicago air
9. Researchers develop new self-training gene prediction program for fungi
10. Case Western Reserve University researchers track Chernobyl fallout
11. Childrens National researchers develop novel anti-tumor vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 /PRNewswire/ ... product subsidiary of Infosys (NYSE: INFY ), and ... global partnership that will provide end customers with ... banking and payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ... area for financial services, but it also plays a fundamental ...
(Date:4/26/2016)... 2016 Research and Markets has ... Market 2016-2020"  report to their offering.  , ,     ... The analysts forecast the global multimodal biometrics market ... the period 2016-2020.  Multimodal biometrics is ... as the healthcare, BFSI, transportation, automotive, and government ...
(Date:4/15/2016)... DUBLIN , April 15, 2016 ... of the,  "Global Gait Biometrics Market 2016-2020,"  report ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait ... CAGR of 13.98% during the period 2016-2020. ... movement angles, which can be used to compute ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 23, 2016 Houston Methodist Willowbrook Hospital ... Sports Association to serve as their official health ... Methodist Willowbrook will provide sponsorship support, athletic training ... association coaches, volunteers, athletes and families. ... Sports Association and to bring Houston Methodist quality ...
(Date:6/23/2016)... ... , ... Supplyframe, the Industry Network for electronics hardware design ... Located in Pasadena, Calif., the Design Lab’s mission is to bring together inventors ... and brought to market. , The Design Lab is Supplyframe’s physical representation of ...
(Date:6/23/2016)... 23, 2016 Andrew ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... journal from touchONCOLOGY, Andrew D Zelenetz , ... cancer care is placing an increasing burden on ... biologic therapies. With the patents on many biologics ...
(Date:6/23/2016)... 2016  Amgen (NASDAQ: AMGN ) today ... life sciences incubator to accelerate the development of ... space at QB3@953 was created to help high-potential life ... many early stage organizations - access to laboratory infrastructure. ... launched two "Amgen Golden Ticket" awards, providing each winner ...
Breaking Biology Technology: